ATR and pancreatic neoplasm: Furthermore, gemcitabine in combination with radiotherapy has shown clinical benefit in lung and pancreatic cancer [41,42] and these data suggests that addition of an ATR inhibitor to such trials may prove beneficial in several types of cancer independently of p53 status.